Royal Bank of Canada »

Ligand Pharmaceuticals In shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2011-09-30 $22k 1.6k 13.99
2011-06-30 $10k 815 12.27

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Bk Nova Cad (BNS)
Ishares Tr Russell 2000 Etf (IWM)
Bank Of Montreal Cadcom (BMO)
JPMorgan Chase & Co. (JPM)
Enbridge (ENB)
Cibc Cad (CM)

View all positions for Royal Bank of Canada

Top funds holding Ligand Pharmaceuticals In

BlackRock
BlackRock
Vanguard Group
Henderson Group
Macquarie Group
Dimensional Fund Advisors
State Street Corporation
Stephens Investment Management Group
Congress Asset Management
Chicago Capital
St. Denis J. Villere & Co
Geode Capital Management
Rice Hall James & Associates
Ashford Capital Management
Impax Asset Management Group

View all funds holding Ligand Pharmaceuticals In